Cholesteryl ester transfer protein (CETP) promotes in vitro transfer of cholesteryl ester (CE) and triglyceride (TG) between lipoproteins. We studied the function of CETP in vivo in rabbit lipoprotein metabolism using a neutralizing monoclonal antibody (MAb, TP1) to CETP. Rabbits were injected with TP1 (n = 8), or irrelevant MAb or saline (control, n = 8), resulting in an initial 71% inhibition of CETP, which fell to 45% after 48 h. HDL CE rose in the inhibited animals, reaching levels that doubled initial and control values at 48 h (P less than 0.001). HDL TG fell reciprocally, but HDL protein did not change, suggesting a CE for TG exchange. VLDL CE/TG decreased. Rabbits were also given [3H]cholesteryl ether HDL (a CE analogue). CETP inhibition delayed the initial clearance of radioactivity from HDL (control 6.8 vs. TP1 4.1 pools/d) and plasma (7.8 vs. 5.2 pools/d). We conclude that CETP plays a quantitatively important role in HDL CE catabolism in the rabbit, promoting the exchange of TG for CE and the clearance of CE from plasma.
Introduction
The incubation of human plasma at 370C results in a net transfer of cholesteryl ester (CE)' from HDL and LDL to VLDL, and a reciprocal movement of triglyceride (TG) from VLDL to LDL and HDL (1, 2) . The transfer of CE, TG, and phospholipids (PL) among the lipoprotein subclasses is mediated by lipid transfer proteins. One of these, a cholesteryl ester transfer protein of M, 74,000, has been purified to homogeneity from human plasma (3) . Monoclonal antibodies (MAb) have been obtained by immunizing mice with this purified CETP. Through the use of these neutralizing MAbs, the Mr 74,000 has been shown to be responsible for all of the CE and TG, and part of the PL transfer activity, in human plasma (4) . In addition, the neutralizing antibodies block the net transfer oflipids in incubated human plasma without affecting the rate of cholesteryl ester formation by lecithin:cholesterol acyltransferase (LCAT) (5) . These MAbs were also found to inhibit CE transfer activity in rabbit plasma, indicating conservation of the epitope between rabbits and humans (4) .
Although the role of CETP in mediating neutral lipid transfer in incubated plasma is clear, its significance in the distribution and catabolism of lipoprotein neutral lipids in vivo is less certain. Human studies shows a progressive shift of cholesteryl ester from HDL to VLDL as serum triglyceride levels increase (6) , perhaps as a result of CETP-mediated transfer of CE from HDL to VLDL (5) . In rats, injection of partially purified human CETP resulted in a shift of HDL cholesteryl ester from larger HDL to VLDL and a depletion of VLDL triglyceride (7) (8) (9) . Interpretation of these studies, however, is limited by the facts that the doses of transfer protein were uncontrolled and that rats naturally lack CETP activity.
In this study, we have examined the role of CETP in the rabbit by injecting neutralizing MAbs, then studying changes in plasma lipoprotein profiles. Based on current knowledge of the actions of CETP, we postulated several effects of CETP inhibition on lipoprotein composition. Primary among these were an increase in HDL CE and a decrease in VLDL CE, with reciprocal changes in TG. We further anticipated that LDL CE might be decreased as a result of depletion of CE in the LDL precursor, VLDL, and that LDL TG would increase as a result ofdecreased transfer to VLDL. In addition, a decrease in HDL PL was hypothesized, due to the known contribution of CETP to PL transfer. Finally, recent evidence suggests that TG enrichment of HDL, after antibody-inhibition of lipoprotein lipase, triggers increased HDL protein turnover, with a resultant fall in HDL protein (Goldberg, I. J., personal communication). This suggested the possibility of a rise in HDL protein if CETP inhibition did result in HDL TG depletion. In a subset of the rabbits studied, we have also examined the effects of CETP neutralization on clearance and tissue uptake of [3H]-cholesteryl ether HDL. Cholesteryl ether is a cholesteryl ester analogue which is also transferred by CETP. We hypothesized that CETP inhibition might result in decreased uptake of CE by the liver.
The inhibition of CETP in the rabbit caused an increase in HDL CE and a decrease in HDL TG. In studied using this modified protocol. To reduce the effects of stress, these rabbits were accommodated to handling and restraint for several days before study and were kept in their usual surroundings during the course of the study. Blood volume removed over a 24-h period was kept to < 20% of total blood volume to minimize hemorrhagic lipemia.
Sampling oftissue radioactivity. At the time of sacrifice (24 or 48 h), rabbits were heparinized with 5,000 U per kg i.v., given a sublethal injection ofxylozine (5 mg/kg) and ketamine (35 mg/kg) and exsanguinated by open cardiac puncture. Perfusion with normal saline instilled through the left ventricle was carried out to a total volume of 2 liters at which time the perfusate was invariably clear. Puncture of the inferior vena cava was performed at the start of perfusion to aid in clearing of the liver. Organs were placed on ice and weighed. Samples of skin, muscle, and abdominal fat were taken and the percentage oftotal body weight of each calculated from published tables (11) (12) (13) . The small intestinal lumen was washed with saline until clear.
Protocols for tissue and RBC digestion were obtained from New England Nuclear. 200-mg samples of each organ in duplicate were digested overnight at 550C with 1.5 ml Protosol. Decolorization with 100 Ml 30% H202 was carried out at 550C for 30 min. Samples were counted in 10 ml Econofluor after a 60-min equilibration period. Total counts in each organ were derived from the weight ofthe organ and the average counts in the digested samples. 250-Ml aliquots of RBCs were digested in 1 ml of a Protosol/ethanol mixture (1:2, vol/vol). Samples were incubated at 60C for 60 min. Decolorization with 500 Ml 30% H202 was carried out at 60°C for 30 min. Samples were counted following the stepwise addition of 15 ml Biofluor and 0.5 ml of 0.5 N HCl. There was a 30-min equilibration period before counting. Organ and RBC samples were counted for 5 min with an open channel in a scintillation counter (LS 5801; Beckman Instruments, Inc., Fullerton, CA) using an Automatic Quench Correction program. 50-Mi aliquots ofplasma were counted in Hydrofluor. The total injected radioactivity was derived from the 5-min plasma and RBC counts. Blood volume was assumed to be 6% ofbody weight. 200-,gl aliquots of each lipoprotein fraction were counted and the total counts in each circulating lipoprotein fraction derived from the plasma volume and volume plasma spun.
Analytical methods. Free and total cholesterol were measured enzymatically (14-16) and cholesteryl ester mass calculated from the difference (mean recovery 72.4±3.0%, i.e., 72.4% of the plasma CE mass was recovered in the isolated lipoproteins). Phospholipid mass was determined enzymatically according to the method of Takayama (17) (mean recovery 81.4±3.0%). Triglyceride enzymatic reagent kits were obtained from Sigma Chemical Co., St. Louis, MO (mean recovery 79.5±2.9%). Cholesterol, TG and PL assays were checked using normal and hyperlipemic human plasma obtained from the Centers for Disease Control. Results were within 13 to 27% of the standard for cholesterol assays, 4 to 34% for triglyceride assays, and 18 to 28% for phospholipid assays. Protein concentration in VLDL was determined according to the method of Lowry (18) . Protein concentration in LDL and HDL was determined using the Bradford reagent system. Lipoprotein mass data were adjusted for small changes in hematocrit occurring at the 24-and 48-h timepoints.
Measurement of LCA T and cholesteryl ester transfer activity.
LCAT activity was measured from the decrease in free cholesterol mass following plasma incubation at 37°C for 0, 0.5, 1, 1.5, and 2 h. CETP activity in rabbit plasma was assayed as described previously (19) .
Statistical methods. Due to the large number of measurements in this study, it was important to control for type I error. Therefore, it was decided a priori to carry out only a limited number of statistical comparisons, based on the original hypotheses and also the changes in lipoprotein composition implied by these changes (see Introduction  and Tables II and III) . In addition, because we were interested primarily in absolute changes in lipoprotein mass regardless of their timecourse, it was decided to define the response of each animal to CETP inhibition as the difference between the zero time value and the mean of all postinhibition values. Comparisons between the two groups (inhibited and control) were made by unpaired t tests.
Three additional comparisons were made related to turnover of [3H]cholesteryl ether. Initial slopes of clearance of radiolabel from HDL and plasma, and the FCR of plasma were calculated, and statistical comparison between groups made by unpaired t test. Radioactivity data in plasma and in HDL were fitted by a sum oftwo exponentials (Ae-"t + Be-), representing the response of a two-compartment system (one intravascular and one extravascular). Two parameters were derived from the two-exponential model: the initial (fractional) slope [(Aa + B#)/A + B] and the (irreversible) fractional clearance rate [A + B/(A/a + B/#l)]. Turnover studies are usually done while the animals are in a steady state (i.e., constant levels ofplasma and HDL CE in this case). However, by making the reasonable assumption that the fractional clearance and turnover rates remain constant even as CE levels change in response to CETP inhibition, it is possible to derive these fractional rates from total radioactivity data.
All results are expressed as means±SEM.
Results
Three neutralizing monoclonal antibodies to human cholesteryl ester transfer protein were obtained by immunizing mice with a purified preparation of CETP, and have been previously described (4 The mean level of inhibition of CE transfer activity achieved in rabbits after intravenous infusion ofMAb is shown in Fig. 2 . After a single MAb infusion at time 0 h, there was an early peak of 70% inhibition with a fairly rapid fall to 47% by 24 h (Fig. 2, upper dashed line) . To achieve a more pronounced inhibition of activity, a second injection of antibody was given at 6 h. This resulted in a more sustained inhibition over the first 24 h, with a decrease to 44% by 48 h (Fig. 2, upper solid line). Control rabbits showed a small but consistent degree of inhibition possibly reflecting stress or blood loss, with accompanying loss ofCETP. This nonspecific inhibition ofCE transfer activity was less pronounced after modification of the protocol to reduce stress and blood loss (lower solid line). There was no difference in degree of inhibition in controls receiving nonspecific monoclonal IgG vs. saline infusion, hence the data have been combined. The compositional data that follow are presented for inhibited and control animals (n = 8 pairs) treated by the modified protocol (i.e., two MAb injections plus minimization of stress and blood withdrawal).
The mean changes from baseline values for HDL CE, and TG after injection of MAb are shown in Fig. 3, A and B, respectively. Most notable was the pronounced rise in HDL CE in the inhibited animals, which continued throughout the time course of the study, and reached levels that were almost twice the initial values (-20 mg/dl). By contrast, there was little change in HDL CE in the control animals. There was a pronounced fall in HDL TG in the TPl-treated animals (Fig. 3  B) . The control animals also showed a transient, less marked fall in HDL TG, which tended to recover by 24 h. (20, 21 HDL CE rose significantly comparing the inhibited and control groups (P < 0.001), and also the postinjection to the initial value in the inhibited group (P < 0.01). HDL TG fell in the inhibited group (P < 0.05) but the mean change was not significantly different from that of the control group. Plasma CE rose in the inhibited group (P < 0.05), but the difference between the groups did not quite reach significance (P = 0.10). Additional hypotheses tested but not found to be statistically significant included changes in VLDL CE and TG, LDL CE and TG, and HDL PL and protein.
The percentage composition of each lipoprotein fraction is presented in Table III . The percent CE in VLDL decreased in the inhibited animals, while it tended to rise in the control group. Primarily as a result of these changes, the CE/TG ratio fell in the inhibited group and rose in the controls. At 24 and 48 h, the CE/TG ratio is significantly different (P < 0.01) between the two groups. Although there were some changes in LDL composition, none were significantly different, comparing control and inhibited animals. Paralleling the changes in HDL mass outlined previously, the percent CE in HDL in the inhibited group rose to twice its starting value, while there was a reciprocal decrease in HDL percent TG. By contrast, there were no changes in HDL CE or TG in the control group. Additionally, there was a fourfold increase in the HDL CE/TG ratio in the inhibited animals, not seen in controls, while the lipid/protein ratio did not change significantly. Thus, the lipid compositional changes ofHDL in CETP-inhibited animals largely constituted a CE for TG substitution. As determined by scanning SDS gels, HDL apoprotein composition showed no change with CETP inhibition and was predominantly apo A-I (85% in controls, 87% in inhibited animals).
As in human studies (5), the rate of cholesterol esterification in rabbit plasma was unaffected by CETP inhibition (data not shown), indicating that the increase in HDL CE was probably due to a decrease in CE catabolism. The effect of CETP inhibition on clearance of [3Hlcholesteryl ether HDL was therefore studied in five pairs of rabbits receiving double injections of MAb. The results for a representative pair of animals (TPl injected and control) are shown in Fig. 4 A. There was a marked delay in clearance of radioactivity from HDL in the inhibited rabbit. Although the control animal showed lower radioactivity at the initial timepoint and recovery of radioactivity during isolation of the lipoproteins was 56.2%, these were not consistent findings in all pairs ofrabbits. For the same pair ofrabbits, CETP inhibition also produced a delay in the clearance of radioactivity from plasma (Fig. 4 B) . This suggests that CETP activity regulates the catabolism of HDL CE and perhaps thereby affects the clearance from whole plasma. Table IV shows the mean rate of removal of [3H]-cholesteryl ether from HDL and plasma for five pairs of animals studied. These values are the means ofthe initial slopes of each animal's decay curve using a two-exponential model (see Methods). There was a significant delay in clearance of radioactivity from both HDL and plasma (P < 0.05 and P < 0.01, respectively) when the inhibited group was compared with the control group. Similar clearance data are not shown for VLDL and LDL, because, in general, radioactivity recovered in these lipoproteins was < 10% of the injected dose and there were no consistent differences between the TPl injected and control groups. At this level of radioactivity, the 2.5% of injected radiolabel not found in cholesteryl ether becomes significant (see Methods).
Since the initial slope reflects both redistribution of radiolabel into a noncirculating pool and irreversible removal from the plasma pool, the plasma FCR was calculated from the area under the plasma decay curve. For the TPl-treated animals, the mean plasma FCR was 2.73±0.25 pools/d, while for the control group, it was 3.80±0.37 pools/d (P < 0.05 by unpaired t test).
The distribution of [3Hlcholesteryl ether radioactivity in tissues is shown for inhibited and control animals in Table V. 132 at 24 h. As noted above, the total counts recovered was somewhat variable, but without clear differences between control and inhibited animals at each timepoint. However, the recovery for both control and inhibited rabbits was less at 6 h than at 24 and 48 h, raising the possibility ofdistribution to a pool not measured. Of interest in this regard, Hussain et al. have established active uptake of CE from chylomicron remnants by rabbit bone marrow cells (22) .
Discussion
The Fig. 2) , largely due to the use of a heterologous MAb (Fig. 1) . The data show that CETP is of major quantitative importance in the catabolism of HDL CE in the rabbit.
A role of CETP in determining HDL CE mass has been suggested previously by injection of CETP into rats (7) (8) (9) and by human studies (6, (23) (24) (25) . Japanese patients with familial hyperalphalipoproteinemia develop large, CE-rich HDL due to the ongoing activity of LCAT without transfer of CE to apo-B containing lipoproteins. A lack of CETP has been postulated as the cause oftheir high HDL and low LDL levels (23, 24) . However, Groener et al., studying an Italian family with familial hyperalphalipoproteinemia, showed these patients to have normal cholesteryl ester transfer activity (25) . High levels of HDL interfere with the assay of CETP activity in plasma. Thus, it is unclear whether a deficiency of CETP activity is secondary to, or the cause of, hyperalphalipoproteinemia. Cross-sectional studies of human lipoprotein composition have suggested that the well known inverse correlation between VLDL TG and HDL CE levels could be due to increased CETP-mediated transfer of CE from HDL to VLDL (6) . Recently, Yen et al. have shown a high correlation between VLDL TG and the rate of transfer of CE into VLDL from HDL in incubated plasma, suggesting that the mass of TG-rich acceptor lipoproteins influences the rate of CE transfer and thereby HDL CE mass (5) . Also, accelerated transfer ofCE from 'HDL to apo B-containing lipoproteins has been found in hypertriglyceridemic patients with dysbetalipoproteinemia, perhaps accounting for the low HDL CE in this condition (19) . However, these findings were different from those reported by others (26) .
In our study, the increase in HDL CE mass was accompanied by a reciprocal fall in HDL TG (Fig. 3) , confirming that CETP mediates exchange of HDL CE with VLDL TG (27) . The molar ratio of the change in mass of HDL CE and TG (inhibited minus control, Fig. 3 ) was -1:1.3, approximating an equimolar hetero-exchange process (27) . Consistent with the suggestion of a hetero-exchange of VLDL TG with HDL CE, there was a significant decrease in the VLDL CE to TG ratio in the inhibited animals, compared with controls. However, the absolute mass of VLDL CE was low and not significantly changed by CETP inhibition, and < 10% of [3H]-cholesteryl ether radioactivity was recovered in VLDL in both sets of animals. These results could be explained by extremely rapid transfer through the VLDL fraction, i.e., transfer of CE from HDL to VLDL with high turnover of VLDL. Large VLDL are the preferred acceptors of CETP-mediated transfer (28) (29) (30) , and are in large part rapidly removed from plasma (31, 32) . Similarly, transfer could have occurred into chylomicrons in these nonfasting rabbits. Although the rabbit is an adequate species in which to study the effects of CETP on lipoprotein metabolism, various limitations were imposed by this model. An unexpected finding in this study was the TG-rich nature of these rabbits' HDL and LDL. Although the plasma TG levels were comparable to values found in the literature for nonfasted rabbits (20, 21, 33, 34) , a major portion of this was in the HDL. A similar phenomenon has been observed in nonfasted rabbits by others, but not to this degree (20, 21) . Presumably, this reflects in part the high level of transfer activity in this species, since with CETP inhibition, the HDL composition came to resemble that of nonfasting rabbits. Stress-mediated hypertriglyceridemia may also have contributed to this TG enrichment. Despite measures to minimize stress, plasma TG increased an average of 54 mg/dl during the accommodation period, just before study, and showed a further increase during the course of the study. Even though total plasma TG and cholesterol values were matched in each pair of rabbits, there were substantial variations in cholesterol and TG distributions among the lipoproteins, reflecting variability between rabbits. This is reflected in large SEMs for lipoprotein composition and differences in absolute levels (not significant) at 0 hours in control versus experimental animals (Tables I and III) . This interanimal variability might have contributed to an insensitivity of this study to subtler changes in lipoprotein composition (e.g., in LDL). An additional concern was that binding of IgG to CETP while the CETP was bound to lipoprotein could have altered lipoprotein metabolism (e.g., by promoting clearance in the spleen). However, the molar ratio of CETP to HDL is of the order of 1:1,000, so that even if all HDL particles containing CETP were cleared by the spleen, this would have a miniscule effect on lipoprotein composition. (35) .
The effect of CETP inhibition on the clearance of CE from plasma suggests that CETP may play a regulatory role in the 
